Vaping-induced lung disease: what the respiratory health-care provider needs to know?

Hot topic
Chairs: S. Belo Ravara (Covilhã, Portugal), F. Blasi (Milan, Italy), M. Gappa (Düsseldorf, Germany), E. Dagli (Istanbul, Turkey)
Aims: to describe the current on-going epidemic of acute lung disease reported in the US and present the clinical characteristics of patients admitted for severe lung disease requiring admission and reporting use of e-cigarettes; to highlight the findings of current studies examining acute and chronic effects of e-cigarettes and supporting their (lack of) safety; to debate what the respiratory physician might consider before recommending for or against e-cigarettes as smoking cessation add; to explore potential public health consequences of the use of e-cigarettes in different patient populations including children and adolescents; To discuss actions that could be initiated by the respiratory health care community to mitigate future problems related to e-cigarettes
Pulmonary illness related to e-cigarette: a new epidemic in the US?
D. Christiani (Boston, United States of America)
Webcast
Webcast
Evidence and e-cigarettes: explaining English exceptionalism (video)
M. McKee (London, United Kingdom)
Webcast
Webcast
E-cigarettes, harm reduction and the ERS’ position
J. Vestbo (Manchester (Greater Manchester), United Kingdom)
Webcast
Webcast